Skip to content

post operative cognitive dysfunction in elderly patients after oral cancer surgery

Effect of dexmedetomidine infusion on post operative cognitive dysfunction in elderly patients after oral cancer surgery and its correlation with ADRA2A genotype: A double blinded randomized controlled study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045528
Enrollment
64
Registered
2022-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Perioperatively iv infusion of Dexmedetomidine will be started at 0./2 mcg/kg/hr and stopped 10 minutes before extubation: Duration of intervention for each group will be 120 minutes De

Sponsors

Department of Anaesthesiology
Lead Sponsor
Department of General Surgery
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients giving written informed consent will be taken. Aged between 50-75years. ASA physiological I and II.

Exclusion criteria

Exclusion criteria: Refusal of patients Patients undergone General anesthesia within 7 days, had taken Alpha-2 agonist within 14 days. Patients who had experienced acute stable angina or myocardial infarcation within previous 6 week. Patients with liver cirrhosis, thrombocytopenia and coagulopathies ,third degree heart block and who had contraindication of neuraxial block, severe bradycardia and has systolic blood pressure less than 90 mmhg. Pregnant female Current psychiatric disorder h/o seizures Known drug allergy to the study. ASA III and ASA IV.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of dexmedetomidine infusion on post-operative cognitive dysfunction in elderly patients following oral cancer surgery.Timepoint: 48 hrs to 72hrs

Secondary

MeasureTime frame
To evaluate the sedative and analgesic effect of Dexmedetomidine after oral cancer surgeries ââ??ª To compare the post-operative requirement of opioid in patients in both groups. ââ??ª To correlate the ADRA2A genotype with the effect of dexmedetomidine infusion on post-operative cognitive dysfunction. ââ??ª To compare the intra-operative hemodynamic changes in both groups. ââ??ª To assess the post-operative recovery status. ââ??ª Number of days in the ICU and the length of hospital stay after surgery.Timepoint: 48hrs

Countries

India

Contacts

Public ContactProf Rajni Gupta

king george medical college

rgkgmu@gmail.com9839288980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026